199911775H : IPBS INSTITUT de PHARMACOLOGIE et de BIOLOGIE STRUCTURALE
- Unité de recherche
Responsables
Directeur - Olivier NEYROLLES à partir du 01/01/2021olivier.neyrolles@ipbs.fr
Directeur adjoint - Fabrice DUMAS à partir du 01/01/2021
fabrice.dumas@ipbs.fr
1 responsable ne souhaite pas publier ses coordonnées.
Adresse : 205 route de Narbonne, BP 64182 31077 TOULOUSE CEDEX 4
Site : http://www.ipbs.fr
Descriptif :
Aucun
Ecole(s) doctorale(s) de rattachement :
- ED 151 - Biologie santé biotechnologies
Rattachée au(x) thème(s) de recherche suivant(s):
- Microenvironment , Cancer and Adipocytes
- Genetic Instability and Transcriptional Regulation
- Cellular Biophysics
- Proteomics and Mass Spectrometry of Biomolecules
- Structural Biophysics
- Mycobacterial interactions with Host Cells
- Immunomodulation by mycobacterial lipids & glycoconjugates
- PICT - Screening plateform of Toulouse
- TRI - Optical imaging and spectroscopy facility
- ANEXPLO - Transgenesis, Zootechnics and Functional Exploration Platform of Toulouse
- Integrative Biological NMR
- Multi-scale modeling of host-pathogen interactions and immune response
- Mycobacterial Envelopes and therapeutic targets
- Vascular biology - Endothelial cells in Immunity, Inflammation and Cancer
- Integrins in Immune Cells
- Immune Detection and Elimination of Pathogens
- Phagocyte architecture and dynamics
- Proteomics Infrastructure of Toulouse
- Molecular Mycobacterial Pathogenesis
- Deciphering and Drugging DNA repair
Liens avec d'autres structures :
Aucun
Aucun
Contact: direction@ipbs.fr
Année de création : 1999
Site ESR :
- Comue de Toulouse, depuis le 01/01/2015
Classement scientifique ERC :
- LS1 : Molecules of Life: Biological Mechanisms, Structures and Functions : Molecular biology, biochemistry, structural biology, molecular biophysics, synthetic and chemical biology, drug design, innovative methods and modelling
- LS3 : Cell Biology, Development, Stem Cells and Regeneration : Structure and function of the cell, cell-cell communication, embryogenesis, tissue differentiation, organogenesis, growth, development, evolution of development, organoids, stem cells, regeneration, therapeutic approaches
- LS6 : Immunity, Infection and Immunotherapy : The immune system, related disorders and their mechanisms, biology of infectious agents and infection, biological basis of prevention and treatment of infectious diseases, innovative immunological tools and approaches, including therapies
- LS4 : Physiology in Health, Disease and Ageing : Organ and tissue physiology, comparative physiology, physiology of ageing, pathophysiology, inter-organ and tissue communication, endocrinology, nutrition, metabolism, interaction with the microbiome, non-communicable diseases including cancer (and except disorders of the nervous system and immunity-related diseases)
Domaine scientifique :
- 5 : Biologie, médecine et santé 2021
- 4 : Chimie 1999
|
CNRS
-
Centre national de la recherche scientifique
SIRET: 18008901303720 (UMR 5089) (établissement tutelle à partir de 1999) |
|
|
INSERM
-
Institut national de la sante et de la recherche medicale
SIRET: 18003604800015 (UMR 5089) (établissement participant à partir de 2003) |
|
|
UT
-
Université de Toulouse EPE
SIRET: 93827139200012 (UMR 5089) (établissement tutelle à partir de 2015) |
Etablissement référent |
-
Libellé(s) de structure
- 18/09/2015 : Institut de pharmacologie et de biologie structurale
- 22/09/2011 : IPBS
- 22/09/2011 : INSTITUT DE PHARMACOLOGIE ET BIOLOGIE STRUCTURALE
-
Responsable
- 01/01/2016 - 31/12/2020 : Alain-Jacques MILON (DIR-ADJ)
- 01/01/2009 - 31/12/2020 : Jean-Philippe GIRARD (DIR)
- 01/01/2016 - 31/12/2020 : Olivier NEYROLLES (DIR-ADJ)
- 01/01/2000 - 31/12/2002 : François AMALRIC (DIR)
- 01/01/2000 - 31/12/2002 : François AMALRIC (DIR)
-
Label et Numéro d'établissement
-
27/07/2011 : UMR 5089
CNRS - Centre national de la recherche scientifique (UMR 5089) -
27/07/2011 : UMR 5089
INSERM - Institut national de la sante et de la recherche medicale (UMR 5089)
-
27/07/2011 : UMR 5089
-
Domaines scientifiques
- 1999 - 2011 : 5- Biologie, médecine et santé
-
Classement scientifique ERC
- 2000 - 2010 : LS1- Molecules of Life: Biological Mechanisms, Structures and Functions : Molecular biology, biochemistry, structural biology, molecular biophysics, synthetic and chemical biology, drug design, innovative methods and modelling
- 2000 - 2010 : LS2- Integrative Biology: from Genes and Genomes to Systems : Genetics, epigenetics, genomics and other ‘omics studies, bioinformatics, systems biology, genetic diseases, gene editing, innovative methods and modelling, ‘omics for personalised medicine
-
Thème(s) de recherche
- - 2020 : High Endothelial Venules (HEVs), Inlammation and Cancer
- - 2020 : Hematopoietic Stem Cell Biology and Cancer
- - 2020 : Sphingolipids in cancer and aging
- - 2020 : Radiobiology and DNA repair
- - 2020 : Genotoxicology
- - 2020 : Transcription and DNA Repair
- - 2020 : Membrane and DNA Dynamics
- - 2020 : NMR and protein-membrane interactions
- - 2020 : Molecular and functional pharmacology of neurpeptides receptors
- - 2020 : Mycobacterial Envelopes : structure, biosynthesis and function
- - 2020 : Molecular Mycobacterial Pathogenesis
- - 2020 : Phagocyte migration and differentiation
-
Etablissements
- 2015 - 2024 : TOULOUSE 3- Université Toulouse 3 - Paul Sabatier
- 2003 - 2014 : TOULOUSE 3- Université Toulouse 3 - Paul Sabatier
- 2000 - 2002 : TOULOUSE 3- Université Toulouse 3 - Paul Sabatier
- 2000 - 2002 : INSA TOULOUSE- Institut National des Sciences Appliquées Toulouse